Johnson & Johnson
JNJ- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000200406
In the last 90 days, Johnson & Johnson insiders filed 0 open-market purchases and 6 sales; 4,701 institutions reported holding it in 13F filings for Q2 2026, worth $456.9B in total; 5 superinvestors hold it, including Markel Group and Fairfax Financial.
Q2 2021 vs. Q1 2021
How the institutions holding Johnson & Johnson changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 3,322 | 48 | 3,333 | +59 |
| Shares | 1.79B | 6.89M | 1.80B | +15.3M (+0.9%) |
| Value | $293.4B | $1.13B | $295.7B | +$3.45B (+1.2%) |
48 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (134)
Institutions that held Johnson & Johnson at the end of Q2 2021 but not at the end of Q1 2021.
Showing the largest 100 of 134 by value.
Sold out (75)
Institutions that held Johnson & Johnson at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (48)
Institutions that held Johnson & Johnson at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.